chartexchange

KNSA
Kiniksa Pharmaceuticals International, plc Class A
stockNASDAQ

Market OpenNov 19, 2026 3:47:08 PM EST
93.74USD-1.378%(-1.31)307,717
Pre-marketNov 19, 2026 8:40:30 AM EST
95.30USD+0.263%(+0.25)
80.13Bid106.42Ask26.29Spread

KNSA Financials

In Q3 FY 2026 (ended ), Kiniksa Pharmaceuticals International, plc Class A (KNSA) reported revenue of $285.97M, net income of $47.35M, operating cash flow of $47.55M, and assets of $983.24M (filed ).

Loading business breakdowns…